Publications
Using a fragment-based approach to identify novel chemical scaffolds targeting the dihydrofolate reductase (DHFR) fromMycobacterium tuberculosis
(2020)
(doi: 10.1101/2020.03.30.016204)
Fragment-Based Design of Mycobacterium Tuberculosis InhA Inhibitors
(2020)
Fragment-Based Design of Mycobacterium Tuberculosis InhA Inhibitors
(2020)
(doi: 10.26434/chemrxiv.10280849)
Inhibiting Mycobacterium tuberculosis CoaBC by targeting a new allosteric site
(2019)
(doi: 10.1101/870154)
Allosteric small-molecule serine/threonine kinase inhibitors
Advances in experimental medicine and biology
(2019)
1163
253
(doi: 10.1007/978-981-13-8719-7_11)
Fragment-Based Design of Mycobacterium Tuberculosis InhA Inhibitors
(2019)
Covalent inactivation of Mycobacterium thermoresistibile inosine-5'-monophosphate dehydrogenase (IMPDH).
Bioorganic & Medicinal Chemistry Letters
(2019)
30
126792
(doi: 10.1016/j.bmcl.2019.126792)
Targeting of fumarate hydratase from Mycobacterium tuberculosis using allosteric inhibitors with a dimeric-binding mode
J Med Chem
(2019)
62
10586
(doi: 10.1021/acs.jmedchem.9b01203)
Structural insights into Escherichia coli phosphopantothenoylcysteine synthetase by native ion mobility–mass spectrometry
Biochemical Journal
(2019)
476
3125
(doi: 10.1042/BCJ20190318)
The Application of Fragment-based Approaches to the Discovery of Drugs for Neglected Tropical Diseases
(2019)
18
(doi: 10.1201/9781351011655-2)
- ‹ previous
- Page 4